Skip to main content

Non-Hodgkin Lymphoma: Diagnosis, Treatment and Side Effects Management

Recorded on May 22, 2020

Click Here to Participate 

Format: Recorded Webinar
1.75 CE Credits Available Until: 
June 22, 2021
 

Target Audience

Nurse practitioners, nurses and oncology social workers involved in the care of patients with non-Hodgkin lymphoma (NHL).

Course Content Level for Social Workers: Intermediate and Advanced
 

Description

This webinar will provide a basic overview of non-Hodgkin Lymphoma (NHL): focusing on strategies for diagnosis and patient management. Risk assessment, treatment options, the role of various members of the healthcare team in addressing treatment goals, guidance for patients and caregivers in treatment decision making, as well as resources for patients, caregivers and healthcare providers will be discussed.
 

Learning Objectives

After completing this activity, participants should be better able to:

  • Describe the various types and subtypes of non-Hodgkin lymphoma
  • Identify tests used to diagnose disease and monitor treatment
  • Explain the overarching goals of treatment for the types of non-Hodgkin lymphoma
  • Explain approved and emerging treatment options including CAR T-cell therapy, and the role of clinical trials
  • Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments
  • Describe the roles of the pharmacist, nurse and social worker in managing patients with NHL

Faculty

Loretta J. Nastoupil, MD
Assistant Professor
Department of Lymphoma/Myeloma
University of Texas MD Anderson Cancer Center
Houston, TX

Irene Lee, PharmD, BCOP
Clinical Pharmacy Specialist, Lymphoma/Myeloma
University of Texas MD Anderson Cancer Center
Houston, TX

Emily Brigham, APRN, CNP, MSN
Advanced Practice Registered Nurse
Department of Hematology, Lymphoma Disease Group
Mayo Clinic
Rochester, MN


Continuing Education

Nurse Practitioner Designation

This activity is approved for 1.63 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20094533. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Registered Nurse Designation

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.75 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/17-12/14/2020. Social workers completing this course receive 1.75 continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.75 clinical CE contact hours for this activity.

Participants must attend the free webinar in its entirety, submit the online evaluation form, and complete and submit the online post-test with a passing score of 70%   to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.


 

Providers

This program is provided by The Leukemia & Lymphoma Society.

 

Click Here to Participate

Participants gain access to the webinar via the registration button above. To view system requirements for this program, please click here.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at infocenter@LLS.org.

 



< Back to Continuing Education